Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance

F. J. F. Herth, B. Schmitt, J. Ficker, M. Pfeifer, D. Ukena, G. Snell, D. Gompelmann, R. Eberhardt (Heidelberg, Berlin, Nürnberg, Regensburg, Bremen, Germany; Melbourne, Australia)

Source: Annual Congress 2009 - Treatment beyond inhalers
Session: Treatment beyond inhalers
Session type: Oral Presentation
Number: 1827
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. J. F. Herth, B. Schmitt, J. Ficker, M. Pfeifer, D. Ukena, G. Snell, D. Gompelmann, R. Eberhardt (Heidelberg, Berlin, Nürnberg, Regensburg, Bremen, Germany; Melbourne, Australia). Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance. Eur Respir J 2009; 34: Suppl. 53, 1827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A safety and feasibility study of the chartis system in subjects with heterogeneous emphysema prior to endobronchial lung volume reduction (ELVR)
Source: Annual Congress 2009 - Treatment beyond inhalers
Year: 2009


The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012


Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012



The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema
Source: Breathe, 16 (1) 200004; 10.1183/20734735.0004-2020
Year: 2020



Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011


Unilateral vs. bilateral endoscopic lung volume reduction in patients with severe heterogeneous emphysema: A comparative randomised case study
Source: Annual Congress 2010 - Interventions for obstructive lung diseases
Year: 2010

Bronchoscopic lung volume reduction with coils (BLVR-Coils) for treatment of patients with severe heterogeneous emphysema and bilaterally incomplete fissures. Its effectiveness in everyday endoscopic practice
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Endoscopic lung volume reduction (ELVR) with the "endobronchial Miyazawa valve" (EMV) in patients with severe emphysema, a prospective pilot study
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011

Single session bilateral endoscopic lung volume reduction therapy in advanced upper lobe and homogeneous emphysema using a tissue sealant
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011



Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema
Source: Eur Respir J 2012; 39: 1084-1089
Year: 2012



Efficacy and safety of bronchoscopic lung volume reduction (BLVR) modalities functioning independent of collateral ventilation in advanced emphysema: Systematic review and meta-analysis
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018

Effect of fissure integrity on the efficacy of bronchoscopic lung volume reduction therapy using a peripheral acting tissue sealant in patients with advanced upper lobe predominant emphysema
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011


Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trial
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011

Biologic lung volume reduction therapy for advanced homogeneous emphysema
Source: Eur Respir J 2010; 36: 20-27
Year: 2010



A dose ranging study of the aeris polymeric lung volume reduction (PLVR) system in patients with advanced upper lobe predominant (ULP) emphysema
Source: Annual Congress 2009 - Treatment beyond inhalers
Year: 2009


The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012


Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Lung volume reduction coil treatment for patients with emphysema: 6-month multicenter feasibility results
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012

Bronchoscopic lung volume reduction with endobronchial valves in selected heterogeneous emphysema: First experience in The Netherlands
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010